Agenda


09:00 Registration and refreshments
09:30 Chair’s opening remarks

Chris Caudle, Senior Communications Consultant and Founder, Make Business Social

09:35 Opening keynote panel: Navigating the current challenges and opportunities facing the pharma comms industry in 2022
  • Defining the role of communications in the future of the pharmaceutical industry
  • Examining opportunities for success: what is the role of digital?
  • What are your focus areas for the future and how can we continue to improve trust in industry?

Paul French, Corporate Affairs Lead, UK and Ireland, Bristol Myers Squibb

Pierre Peotta, External Communications Manager, Abcam

Lisa Timothy, UK External Affairs Director, Takeda

10:20 Importance of in-depth insight for authentic storytelling
  • How storytelling changed in the last two years – the 7 narratives in today’s world
  • The one metric journalists today care about most
  • Authenticity in the post-influencer era

Zuzanna Grzeskiewicz, Head of Communications, Sanofi Vaccines UK & Ireland

10:45 Resetting relationships: the changing role of pharma in a new reality
  • How have the key relationships between communicators, the industry, healthcare providers and patients fundamentally changed?
  • How does the industry need to adapt to these changes to ensure relationships remain strong?
  • What does the new reality look like for these relationships and what are the next steps to take?

Ben Fisher, Head of Health and Director, Scientific Engagement, UK, WE Communications

11:05 Networking break
11:35 Creating trust – what does the public think about the pharma industry and what does it mean for how we communicate?
  • What does the research tell us about our reputation and how has the pandemic changed this?
  • What this means for how we build trust in the industry as a force for good
  • How we can use this evidence to get better at communicating our story

Elliot Dunster, Executive Director, Corporate Affairs and Devolved Nations, Association of the British Pharmaceutical Industry (APBI)

12:00 New Normal, Same Cancer: the power in prioritising patient-centric campaigns
  • Why putting patient advocacy at the heart of your comms creates the most compelling campaigns
  • Collaboration is key: how working with a range of stakeholders helped create a campaign that activated the public to take urgent action
  • Doing things differently: how going beyond the standard comms toolkit and providing long-term rollout support enabled the campaign to take on a life of its own

Hannah Saul, Global Director, Oncology Patient Affairs, AstraZeneca

Michelle Marchione, Global Oncology Patient Affairs, AstraZeneca

12:35 Building better relationships - what the NHS want from pharma comms
  • Understanding the patient diagnosis crises and promoting what we all have to gain from NHS recovery
  • Rethinking what should really be happening in healthcare in the UK; what is your role in shining a light on that?
  • How can we tell the story of the NHS building back better whilst simultaneously supporting that effort

James Lyons, Director of Communications, NHS England and NHS Improvement

12:55 From ‘blah’ to brilliant: 10 golden rules to tell a better corporate story
  • Learn the 10 golden rules for telling a better story to enhance reputations, recognition & resilience
  • Identify, articulate and propagate a clear brand positioning, purpose and strategy
  • One that is clear, memorable and ensures differentiation in an increasingly competitive fight for audience mindshare

Emma Gorton, Deputy Managing Director, Hanover

13:10 Networking lunch
14:10 Knowing who should deliver your pharma comms for maximum impact
  • The unexpected benefits in using influencers or social media drive campaign awareness and build back trust with your audience
  • Familiarity breeds empathy: why you need a diverse range of spokespeople when targeting a diverse range of audiences

Puja Parmer, Senior Advisor to the Mayor - Marketing, Mayor of London

14:35 How collaboration and non-traditional partnerships can drive your organisation forward
  • How pharma companies can form more effective partnerships with charities in order to boost patient-focused healthcare solutions
  • Technology partnerships and other methods to help patients, and the public as a whole, embrace technology driven patient care
  • What pharmacomms professionals can do to enhance their company’s reputation to ensure their business can compete for the best partners

Amanda Stuart, Head of Communications and Engagement, Novartis UK

15:00 Networking break
15:25 The rise of a new professional development standard and how it will benefit your organisation
  • How we all benefit as a professional from the new CPD Standards
  • Understanding the outline of the requirements to achieve the standards and the core competency spheres for healthcare communicators
  • Gain a practical understanding of how to receive annual certification

Mike Dixon, CEO, Healthcare Communications Association (HCA) Meg Morgan, Managing Director, Integrated Communications at Real Chemistry and Member of HCA’s Professional Development Committee

15:50 Fireside chat: Communicating effectively with diverse communities to reduce UK healthcare inequalities
  • Learn what you can do for under-represented and diverse communities to help build trust and encourage take up of health programmes
  • Promoting trust and transparency: balancing representation and expertise
  • The value in removing bias and understanding the different groups and demographics at stake

Joyce Jeffery, Head of Therapy Area and Brand Communications, Novartis UK

16:10 Chair’s closing remarks
16:15 End of conference

Speaking opportunities
Please contact Charli Veale on charli.veale@haymarket.com

Sponsorship and exhibition opportunities
Please contact James on +44 (0)20 8267 4233 or james.butters@haymarket.com

General enquiries
Please call +44 (0)20 8267 4011 or email conferences@haymarket.com